Wellnex Life Limited
WNX · AIM · Retail · mcap £4.0m · 5.5p
Wellnex Life is an Australian consumer health company that owns and sells over-the-counter brands and makes products for others under contract. It sells mainly through Australian retailers and pharmacies and is expanding into the UK, New Zealand and other markets.
| Target | Promise | Said | Status |
|---|---|---|---|
| 2025 | |||
| 6 May 2025 | Eliminate over A$13m of debt, saving about A$1.4m a year in costs, after the AIM placing. | 21 Mar 2025 | ✓ Kept |
|
Result
May 2025 updates confirm about A$13m of debt extinguished following the AIM listing, with annual savings of about A$1.4m. “with the extinguishment of circa A$13 million in debt following the AIM IPO”6 May 2025 · Board and Management Changes “Successful admission on 21 March 2025 to the AIM Market of the London Stock Exchange (”12 May 2025 · Trading Update |
|||
| 7 Nov 2025 | Agree a repayment schedule for the Bozinovski loan by 7 November 2025 (originally 31 October). | 20 Oct 2025 | ✓ Kept |
|
Also stated 3 Nov 2025
Result
On 10 November 2025 repayment was scheduled for 20 April 2026, so the schedule was agreed, three days after the revised date. “the parties have reached an agreement on a repayment schedule, with the majority of the Loan repayable on 20 April 2026”10 Nov 2025 · Update on Loan Repayment |
|||
| 31 Dec 2025 | Reach EBITDA breakeven by Q2 FY2026. | 16 Dec 2025 | ✓ Kept |
|
Result
January 2026 update says the group operated at breakeven in Q2; half-year results confirm operating breakeven reached. “The Group closed Q2 FY26 operating at breakeven, providing a solid platform entering H2 FY26.”16 Jan 2026 · Market Update “The Group closed Q2 FY26 operating at breakeven, providing a solid platform entering 2HFY26”27 Feb 2026 · Half Yearly Report and Accounts |
|||